Targeted Proteomic Analysis of 14-3-3ς, a p53 Effector Commonly Silenced in Cancer

This publication has 45 references indexed in Scilit:

• Downregulation of 14-3-3σ in ovary, prostate and endometrial carcinomas is associated with CpG island methylation
  Laboratory Investigation, 2005
• Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression
  Oncogene, 2004
• The 14-3-3 cancer connection
  Nature Reviews Cancer, 2003
• Analysis of 14-3-3σ expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma
  Oncogene, 2003
• Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers
  Oncogene, 2002
• The G2/M Regulator 14-3-3ς Prevents Apoptosis through Sequestration of Bax
  Journal of Biological Chemistry, 2001
• Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma
  Oncogene, 2000
• High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
  Proceedings of the National Academy of Sciences, 2000
• 14-3-3σ is required to prevent mitotic catastrophe after DNA damage
  Nature, 1999
• Is a p53-Regulated Inhibitor of G2/M Progression
  Molecular Cell, 1997